Medical Communications
Withings announces hands-free connected in-home urine lab
January 6, 2023 Medical Communications
Connected health firm Withings has unveiled its new in-home biomarker analysis platform U-Scan. It is hoped the device will utilise …
Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs
January 5, 2023 Medical Communications
AMSTERDAM, THE NETHERLANDS, 5 January 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for …
FDA accepts application for nirsevimab as first protective option for RSV in infants
January 5, 2023 Medical Communications
The FDA has accepted an application for nirsevimab as the first protective option to combat respiratory syncytial virus (RSV) disease …
FDA expands access to abortion pills
January 4, 2023 Medical Communications
Following new rules from the FDA under the Biden administration, patients can now obtain the abortion pill mifepristone from retail …
Novartis pays $245m to settle Exforge generic pay-for-delay lawsuit
January 4, 2023 Medical Communications
Swiss pharma company Novartis will settle a classic generic pay-for-delay legal battle with direct purchasers, indirect purchasers and retailers regarding …
FDA grants Breakthrough Device Designation for Burning Rock’s multi-cancer detecting test
January 4, 2023 Medical Communications
Burning Rock, a Chinese biotech company which focuses on the applications of next-generation sequencing (NGS) technology in the field of …
FDA expected to make decision on controversial Alzheimer’s drug this week
January 4, 2023 Medical Communications
The FDA are expected to come to a decision on Eisai and Biogen’s Alzheimer’s drug lecanemab by the end of …
MediWound receives FDA approval for NexoBrid
January 3, 2023 Medical Communications
Israeli biopharma company MediWound has secured FDA approval for its wound care product NexoBrid (anacaulase-bcdb). US-based biopharma company Vericel will …
Datar blood test receives FDA Breakthrough Designation
January 3, 2023 Medical Communications
Datar Cancer Genetics has secured FDA Breakthrough Designation for their blood test used to detect inaccessible brain tumours, where traditional …
BioNTech begins phase 1 trial for malaria vaccine
December 23, 2022 Medical Communications
BioNTech has announced the start of its new first-in-human phase 1 trial for BNT165b1, a candidate from its programme which …
Celltrion submits application for CT-P13 SC to FDA
December 23, 2022 Medical Communications
Celltrion has announced that it has finalised its submission of a biologics license application for the subcutaneous version of a …
COVID-19 antiviral treatment shown to speed up recovery in trial
December 23, 2022 Medical Communications
Molnupiravir, made by Merck, Sharp and Dohme (MSD), has been found to reduce the recovery time of COVID-19 patients, however …
Treatment for rare, paediatric growth hormone deficiency recommended by NICE for use on the NHS
December 22, 2022 Medical Communications
Walton Oaks, 22 December 2022 – Pfizer Ltd today announces that the National Institute for Health and Care Excellence (NICE) …
AstraZeneca shares two new drug approvals in the EU
December 22, 2022 Medical Communications
On Wednesday, AstraZeneca announced two drug approvals in the European Union (EU). The first being Imfinzi’s approval for the treatment …
Everest Medicines and licensing partner Pfizer receive FDA and EMA approval for ulcerative colitis drug
December 22, 2022 Medical Communications
Everest Medicines, a biopharmaceutical company, has announced that its licensing partner, Pfizer, has received acceptance from the FDA for a …
Latest content
October 26, 2026
